187 related articles for article (PubMed ID: 24349306)
1. Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection.
Ohs I; Windmann S; Wildner O; Dittmer U; Bayer W
PLoS One; 2013; 8(12):e82528. PubMed ID: 24349306
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
Bayer W; Tenbusch M; Lietz R; Johrden L; Schimmer S; Uberla K; Dittmer U; Wildner O
J Virol; 2010 Feb; 84(4):1967-76. PubMed ID: 20007267
[TBL] [Abstract][Full Text] [Related]
3. Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.
Bayer W; Lietz R; Ontikatze T; Johrden L; Tenbusch M; Nabi G; Schimmer S; Groitl P; Wolf H; Berry CM; Uberla K; Dittmer U; Wildner O
Retrovirology; 2011 Sep; 8():75. PubMed ID: 21943056
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
[TBL] [Abstract][Full Text] [Related]
6. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.
Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W
Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802
[TBL] [Abstract][Full Text] [Related]
7. Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
Lietz R; Bayer W; Ontikatze T; Johrden L; Tenbusch M; Storcksdieck Genannt Bonsmann M; Uberla K; Dittmer U; Wildner O
J Virol; 2012 Feb; 86(3):1706-16. PubMed ID: 22090142
[TBL] [Abstract][Full Text] [Related]
8. Interference of retroviral envelope with vaccine-induced CD8
Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
[TBL] [Abstract][Full Text] [Related]
10. Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection.
Dittmer U; Werner T; Kraft AR
Viral Immunol; 2008 Dec; 21(4):459-67. PubMed ID: 19115935
[TBL] [Abstract][Full Text] [Related]
11. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
[TBL] [Abstract][Full Text] [Related]
12. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
13. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
14. Immunodominance of Adenovirus-Derived CD8
Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.
Dittmer U; Race B; Hasenkrug KJ
J Virol; 1999 Oct; 73(10):8435-40. PubMed ID: 10482595
[TBL] [Abstract][Full Text] [Related]
16. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
17. The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus).
Strestik BD; Olbrich ARM; Hasenkrug KJ; Dittmer U
J Gen Virol; 2001 Jun; 82(Pt 6):1349-1354. PubMed ID: 11369878
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
Dittmer U; Brooks DM; Hasenkrug KJ
J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
[TBL] [Abstract][Full Text] [Related]
19. Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus.
Chen Z; Guo X; Ge X; Jia H; Yang H
Vaccine; 2008 Jan; 26(4):573-80. PubMed ID: 18162265
[TBL] [Abstract][Full Text] [Related]
20. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
